Renascience

Renascience Earnings Yield

The Earnings Yield of Renascience (4889.T) as of Nov 19, 2026 is -1.25 %. In the previous year, Earnings Yield was 0.47 % — a change of -365.61% (lower).

Earnings Yield

-1.25 %

YoY

-365.61%

Last updated:

Earnings Yield of Renascience is 2026 -1.25 % . Earnings Yield of Renascience was 2025 0.47 % . It decreases by -365.61% lower compared to the previous year.

The Renascience Earnings Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings Yield
Date
Earnings Yield
Jan 1, 2020
-0.76 JPY
Jan 1, 2021
-0.41 JPY
Jan 1, 2022
-1.05 JPY
Jan 1, 2023
-1.39 JPY
Jan 1, 2024
-1.07 JPY
Jan 1, 2025
0.47 JPY
Jan 1, 2026
-1.25 JPY
The Renascience Earnings Yield history
YEAREarnings YieldYoY
-1.25 %-365.61%
0.47 %-143.91%
-1.07 %-23.07%
-1.39 %+32.05%
-1.05 %+154.15%
-0.41 %-45.62%
-0.76 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Renascience Stock analysis

What does Renascience do? Renascience, Inc. develops and sells pharmaceuticals, focusing on drugs for four non-infectious aging-related diseases: cancer, diabetes, respiratory diseases, and cardiovascular diseases. The company collaborates with physicians in research and development of pharmaceuticals, medical devices, and AI solutions for medical problems. Its products target aging-related health issues, including women's and children's diseases and solutions for COVID-19 infection. The firm's revenue comes from the sale of developed pharmaceuticals, medical devices, and AI solutions. Physicians and medical institutions are key buyers of its products, as the company's R&D is conducted in collaboration with them. The primary market segments are aging populations suffering from chronic conditions and healthcare providers seeking innovative medical solutions. Renascience, Inc. operates with a small team of three full-time employees, emphasizing focused R&D on specific medical challenges. Its business model centers on developing targeted therapies for high-impact diseases, leveraging partnerships with physicians to address unmet medical needs in aging-related health conditions. Renascience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Renascience stock

Earnings Yield of Renascience is -1.25 % in 2026.

Earnings Yield of Renascience changed from 0.47 % to -1.25 %, representing a -365.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield Renascience since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's Renascience with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Renascience

All Key Metrics — Renascience